Dongsheng Tu
机构: Professor of Biostatistics, Queen's University at Kingston, Canada
每年引用次数
引用次数
引用: 50,542
H-指数: 84
I10-指数 : 235
出版物: 544
Abstract PD4-02: Canadian cancer trials group trial IND.231: A phase 1 trial evaluating CX-5461, a novel first-in-class G-quadruplex stabilizer in patients with advanced solid tumors enriched for DNA-repair deficiencies
John Hilton , Karen Gelmon , David Cescon , Anna Tinker
Cancer Research 80
2
2020
Differential Role of Estrogen Receptor Beta in Early Versus Metastatic Non-small Cell Lung Cancer
Sri Navaratnam , Georgios Skliris , Gefei Qing , Shantanu Banerji
Hormones and Cancer 3 ( 3) 93 -100
45
2012
Quality of life (QoL) assessment in patients (pts) with K-RAS wild-type (WT) chemotherapy refractory metastatic colorectal cancer (mCRC) treated with cetuximab (CET) plus brivanib alaninate (BRIV) or placebo: Results of the NCIC Clinical Trials Group and AGITG CO.20 trial.
Jolie Ringash , Heather-Jane Au , Lillian L. Siu , Jeremy D. Shapiro
Journal of Clinical Oncology 30 542 -542
1
2012
Immune related adverse events (irAE) with platinum chemotherapy (CT) with durvalumab (D) ± tremelimumab (T): CCTG IND226.
Nathalie Daaboul , Isabelle Gauthier , Dongsheng Tu , Pamela Brown-Walker
Journal of Clinical Oncology 35 ( 15_suppl) 3058 -3058
3
2017
Age as a predictive and prognostic factor for targeted therapy treatment in metastatic chemorefractory colorectal cancer (CRC): An analysis of NCIC CTG CO.17 and CO.20.
Connor Wells , Lillian L Siu , Jeremy David Shapiro , Dongsheng Tu
Journal of Clinical Oncology 35 ( 15_suppl) 3555 -3555
2017
A randomized phase II study of pelareorep (REO) plus docetaxel vs. docetaxel alone in patients with metastatic castration resistant prostate cancer (mCRPC): Canadian Cancer Trials Group study IND 209.
Bernhard J. Eigl , Eric Winquist , Dongsheng Tu , Sebastien J. Hotte
Journal of Clinical Oncology 35 5021 -5021
1
2017
A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group Trial
Derek J. Jonker , Patricia A. Tang , Hagen Kennecke , Stephen A. Welch
Clinical Colorectal Cancer 17 ( 3) 231 -239.e7
17
2018
Outcomes of Older Patients (≥ 70 Years) Treated With Targeted Therapy in Metastatic Chemorefractory Colorectal Cancer: Retrospective Analysis of NCIC CTG CO.17 and CO.20.
J. Connor Wells , Dongsheng Tu , Lillian L. Siu , Jeremy D. Shapiro
Clinical Colorectal Cancer 18 ( 1)
3
2019
Optimal Two-Stage Design for the Phase II Cancer Clinical Trials With Responses and Early Progression as Co-primary Endpoints
Xianming Tan , Glen Takahara , Dongsheng Tu
Statistics in Biopharmaceutical Research 2 ( 3) 348 -354
1
2010
A randomized trial (MA.17R) of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer.
Paul E. Goss , James N. Ingle , Kathleen I. Pritchard , Nicholas J. Robert
Journal of Clinical Oncology 34
10
2016
Patient-reported outcomes from MA.17R: A randomized trial of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer.
Julie Lemieux , Paul E. Goss , Wendy R. Parulekar , James N. Ingle
Journal of Clinical Oncology 34 ( 18_suppl) LBA506 -LBA506
5
2016
OV21/PETROC: A randomized Gynecologic Cancer Intergroup (GCIG) phase II study of intraperitoneal (IP) versus intravenous (IV) chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer (EOC).
Helen Mackay , Christopher J. Gallagher , Wendy R. Parulekar , Jonathan A. Ledermann
Journal of Clinical Oncology 34 ( 18_suppl) LBA5503 -LBA5503
12
2016
Hypertension as a predictor of outcome and treatment response to cetuximab: A retrospective analysis of NCIC CTG CO.17.
Shelly Sud , Christopher J O'Callaghan , Caleb Jonker , Christos Stelios Karapetis
Journal of Clinical Oncology 34 ( 4) 256 -256
2016
A phase Ib study of selumetinib in patients (pts) with previously untreated metastatic Non-Small Cell Lung Cancer (NSCLC) receiving standard chemotherapy: NCIC Clinical Trials Group IND.215. NCT01783197.
Garth Andrew Nicholas , John R Goffin , Scott Andrew Laurie , Andrew George Robinson
Journal of Clinical Oncology 33 ( 15_suppl) 8046 -8046
4
2015
Data-driven ridge regression for Aalen’s additive risk model
Audrey Boruvka , Glen Takahara , Dongsheng Tu
Statistics & Probability Letters 109 189 -193
2016
A Phase I Pharmacokinetic and Pharmacodynamic Study of OGX-011, a 2′-Methoxyethyl Antisense Oligonucleotide to Clusterin, in Patients With Localized Prostate Cancer
Kim N. Chi , Elizabeth Eisenhauer , Ladan Fazli , Edward C. Jones
Journal of the National Cancer Institute 97 ( 17) 1287 -1296
249
2005
CCTG CO.26 trial: A phase II randomized study of durvalumab (D) plus tremelimumab (T) and best supportive care (BSC) versus BSC alone in patients (pts) with advanced refractory colorectal carcinoma (rCRC).
Eric Xueyu Chen , Derek J. Jonker , Hagen F. Kennecke , Scott R. Berry
Journal of Clinical Oncology 37 481 -481
24
2019
Expanded RAS and BRAF V600 testing as predictive biomarkers for single agent cetuximab in the randomized phase III CO.17 trial.
Jonathan M. Loree , Anthony Dowers , Dongsheng Tu , Christopher J. O'Callaghan
Journal of Clinical Oncology 37 ( 4) 537 -537
2
2019
CO.28: Neoadjuvant Chemotherapy, Excision and Observation (NEO) for early rectal cancer.
Hagen F. Kennecke , Carl J Brown , Rebecca Auer , Sebastien Drolet
Journal of Clinical Oncology 37
2019
Dose-dense early postoperative intraperitoneal chemotherapy in ovarian cancer: Randomized, phase II trial.
Rongyu Zang , Tingyan Shi , Rong Jiang , Hong Pu
Journal of Clinical Oncology 37 5514 -5514
2019
Lois Shepherd Lesley Seymour Kathleen I. Pritchard C Karapetis John Zalcberg Jeremy Shapiro Timothy Price Christopher J O'Callaghan Michael Brundage Wendy R. Parulekar Ian Gilron John Goffin Lillian Siu Ronald R. Holden Nancy E Davidson Penelope Bradbury Stephen KL Chia Zee Chung-Ying Benny Ming Tsao Sharlene Gill